Conclusions regarding the efficacy of treatments for neuroleptic malignant syndrome should be tempered given poor quality data, regardless of the analysis conducted

Detalles Bibliográficos
Autores principales: Roberts, Darren M, Roberts, Jason A
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2007
Materias:
Letter
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2206394/
https://www.ncbi.nlm.nih.gov/pubmed/17488492
http://dx.doi.org/10.1186/cc5786

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2206394/
https://www.ncbi.nlm.nih.gov/pubmed/17488492
http://dx.doi.org/10.1186/cc5786

Ejemplares similares